Literature DB >> 16258764

A comparison of PET imaging characteristics of various copper radioisotopes.

Heather Ann Williams1, Simon Robinson, Peter Julyan, Jamal Zweit, David Hastings.   

Abstract

PURPOSE: PET radiotracers which incorporate longer-lived radionuclides enable biological processes to be studied over many hours, at centres remote from a cyclotron. This paper examines the radioisotope characteristics, imaging performance, radiation dosimetry and production modes of the four copper radioisotopes, ( 60)Cu,( 61)Cu,( 62)Cu and( 64)Cu, to assess their merits for different PET imaging applications.
METHODS: Spatial resolution, sensitivity, scatter fraction and noise-equivalent count rate (NEC) are predicted for( 60)Cu,( 61)Cu,( 62)Cu and( 64)Cu using a model incorporating radionuclide decay properties and scanner parameters for the GE Advance scanner. Dosimetry for( 60)Cu,( 61)Cu and( 64)Cu is performed using the MIRD model and published biodistribution data for copper(II) pyruvaldehyde bis(N(4)-methyl)thiosemicarbazone (Cu-PTSM).
RESULTS: (60)Cu and( 62)Cu are characterised by shorter half-lives and higher sensitivity and NEC, making them more suitable for studying the faster kinetics of small molecules, such as Cu-PTSM.( 61)Cu and( 64)Cu have longer half-lives, enabling studies of the slower kinetics of cells and peptides and prolonged imaging to compensate for lower sensitivity, together with better spatial resolution, which partially compensates for loss of image contrast.( 61)Cu-PTSM and( 64)Cu-PTSM are associated with radiation doses similar to [(18)F]-fluorodeoxyglucose, whilst the doses for( 60)Cu-PTSM and( 62)Cu-PTSM are lower and more comparable with H(2) (15)O.
CONCLUSION: The physical and radiochemical characteristics of the four copper isotopes make each more suited to some imaging tasks than others. The results presented here assist in selecting the preferred radioisotope for a given imaging application, and illustrate a strategy which can be extended to the majority of novel PET tracers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258764     DOI: 10.1007/s00259-005-1906-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  33 in total

1.  Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography.

Authors:  M J Ribeiro; P Almeida; D Strul; N Ferreira; C Loc'h; V Brulon; R Trébossen; B Mazière; B Bendriem
Journal:  Eur J Nucl Med       Date:  1999-07

2.  Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.

Authors:  Y Fujibayashi; H Taniuchi; Y Yonekura; H Ohtani; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1997-07       Impact factor: 10.057

3.  Performance of a block detector PET scanner in imaging non-pure positron emitters--modelling and experimental validation with 124I.

Authors:  S Robinson; P J Julyan; D L Hastings; J Zweit
Journal:  Phys Med Biol       Date:  2004-12-21       Impact factor: 3.609

4.  Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.

Authors:  M A Green; C J Mathias; M J Welch; A H McGuire; D Perry; F Fernandez-Rubio; J S Perlmutter; M E Raichle; S R Bergmann
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

5.  62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases.

Authors:  M A Flower; J Zweit; A D Hall; D Burke; M M Davies; M J Dworkin; H E Young; J Mundy; R J Ott; V R McCready; P Carnochan; T G Allen-Mersh
Journal:  Eur J Nucl Med       Date:  2001-01

6.  Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution.

Authors:  C S Levin; E J Hoffman
Journal:  Phys Med Biol       Date:  1999-03       Impact factor: 3.609

7.  Performance characteristics of a whole-body PET scanner.

Authors:  T R DeGrado; T G Turkington; J J Williams; C W Stearns; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1994-08       Impact factor: 10.057

8.  Development of a high performance zinc-62/copper-62 radionuclide generator for positron emission tomography.

Authors:  J Zweit; R Goodall; M Cox; J W Babich; G A Potter; H L Sharma; R J Ott
Journal:  Eur J Nucl Med       Date:  1992

9.  64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

Authors:  C J Anderson; F Dehdashti; P D Cutler; S W Schwarz; R Laforest; L A Bass; J S Lewis; D W McCarthy
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

10.  High-yield production of recombinant antibody fragments in HEK-293 cells using sodium butyrate.

Authors:  Jürgen Grünberg; Karin Knogler; Robert Waibel; Ilse Novak-Hofer
Journal:  Biotechniques       Date:  2003-05       Impact factor: 1.993

View more
  24 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Hybrid PET-optical imaging using targeted probes.

Authors:  Matthias Nahrendorf; Edmund Keliher; Brett Marinelli; Peter Waterman; Paolo Fumene Feruglio; Lioubov Fexon; Misha Pivovarov; Filip K Swirski; Mikael J Pittet; Claudio Vinegoni; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

3.  ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine.

Authors:  Ferid Haddad; Ludovic Ferrer; Arnaud Guertin; Thomas Carlier; Nathalie Michel; Jacques Barbet; Jean-François Chatal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-09       Impact factor: 9.236

4.  When the prey gets too big: an uncommon road accident involving a motorcyclist, a car and a bird.

Authors:  J Tschui; N Feddern; N Schwendener; L Campana; S Utz; M Schweizer; C Jackowski; W D Zech
Journal:  Int J Legal Med       Date:  2015-04-17       Impact factor: 2.686

Review 5.  Production of radiometals in liquid targets.

Authors:  Sergio J C do Carmo; Peter J H Scott; Francisco Alves
Journal:  EJNMMI Radiopharm Chem       Date:  2020-01-10

6.  64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy.

Authors:  Rodney J Hicks; Price Jackson; Grace Kong; Robert E Ware; Michael S Hofman; David A Pattison; Timothy A Akhurst; Elizabeth Drummond; Peter Roselt; Jason Callahan; Roger Price; Charmaine M Jeffery; Emily Hong; Wayne Noonan; Alan Herschtal; Lauren J Hicks; Amos Hedt; Matthew Harris; Brett M Paterson; Paul S Donnelly
Journal:  J Nucl Med       Date:  2018-11-15       Impact factor: 10.057

7.  Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment.

Authors:  Hao Hong; Yin Zhang; Hakan Orbay; Hector F Valdovinos; Tapas R Nayak; Jero Bean; Charles P Theuer; Todd E Barnhart; Weibo Cai
Journal:  Mol Pharm       Date:  2013-01-14       Impact factor: 4.939

8.  PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragment.

Authors:  Yin Zhang; Hao Hong; Hakan Orbay; Hector F Valdovinos; Tapas R Nayak; Charles P Theuer; Todd E Barnhart; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-24       Impact factor: 9.236

9.  Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine.

Authors:  D P Holschneider; J Yang; T R Sadler; N B Galifianakis; M H Bozorgzadeh; J R Bading; P S Conti; J-M I Maarek
Journal:  Brain Res       Date:  2008-07-19       Impact factor: 3.252

10.  PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.

Authors:  Terence Z Wong; Jeffrey L Lacy; Neil A Petry; Thomas C Hawk; Thomas A Sporn; Mark W Dewhirst; Gordana Vlahovic
Journal:  AJR Am J Roentgenol       Date:  2008-02       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.